We are live on ! Find out more
AC

AXQ Capital Portfolio holdings

AUM $777M
1-Year Est. Return 9.87%
This Fund
S&P 500
This Quarter Est. Return
+7.11%
1 Year Est. Return
+9.87%
3 Year Est. Return
+23.94%
5 Year Est. Return
10 Year Est. Return
AUM
$417M
AUM Growth
+$41.6M
Cap. Flow
+$20.4M
Cap. Flow %
4.88%
Top 10 Hldgs %
6.44%
Holding
929
New
309
Increased
146
Reduced
136
Closed
333

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$3.47M
2
MCD icon
McDonald's
MCD
+$3.11M
3
VRSN icon
VeriSign
VRSN
+$2.78M
4
KMB icon
Kimberly-Clark
KMB
+$2.41M
5
MDLZ icon
Mondelez International
MDLZ
+$2.39M

Top Sells

Rank Stock Value
1
AON icon
Aon
AON
+$2.38M
2
CI icon
Cigna
CI
+$2.28M
3
JNPR
Juniper Networks
JNPR
+$2.25M
4
AEP icon
American Electric Power
AEP
+$2.18M
5
RY icon
Royal Bank of Canada
RY
+$2.05M

Sector Composition

Rank Sector Weight
1 Technology 20.12%
2 Industrials 14.93%
3 Financials 14.59%
4 Consumer Discretionary 12.53%
5 Healthcare 11.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENS icon
476
EnerSys
ENS
$6.92B
$239K 0.06%
+2,534
New +$238K
ALIT icon
477
Alight
ALIT
$380M
$239K 0.06%
+1,213
New +$220K
VRNT
478
DELISTED
Verint Systems
VRNT
$239K 0.06%
+7,200
New +$216K
JNPR
479
DELISTED
Juniper Networks
JNPR
$237K 0.06%
6,400
-61,700
-91% -$2.25M
CNNE icon
480
Cannae Holdings
CNNE
$654M
$237K 0.06%
10,641
-2,034
-16% -$43K
CHE icon
481
Chemed
CHE
$7.14B
$236K 0.06%
+367
New +$223K
PFS icon
482
Provident Financial Services
PFS
$3.27B
$235K 0.06%
+16,110
New +$256K
NICE icon
483
Nice
NICE
$5.82B
$235K 0.06%
900
-600
-40% -$136K
MD icon
484
Pediatrix Medical
MD
$2.11B
$234K 0.06%
23,374
+4,870
+26% +$45.3K
BILL icon
485
BILL Holdings
BILL
$4.81B
$234K 0.06%
+3,400
New +$238K
NNI icon
486
Nelnet
NNI
$4.89B
$233K 0.06%
2,458
-438
-15% -$38.5K
KELYA icon
487
Kelly Services Class A
KELYA
$528M
$232K 0.06%
+9,274
New +$208K
FOUR icon
488
Shift4
FOUR
$4.23B
$231K 0.06%
+3,500
New +$263K
CSIQ icon
489
Canadian Solar
CSIQ
$1.05B
$231K 0.06%
+11,700
New +$252K
PKX icon
490
POSCO
PKX
$16.6B
$231K 0.06%
2,940
-617
-17% -$50.8K
GTLB icon
491
GitLab
GTLB
$6.11B
$227K 0.05%
3,900
-2,100
-35% -$138K
ACCO icon
492
Acco Brands
ACCO
$402M
$227K 0.05%
40,540
+24,113
+147% +$143K
SBS icon
493
Sabesp
SBS
$19.1B
$226K 0.05%
69,113
-99,021
-59% -$302K
IFF icon
494
International Flavors & Fragrances
IFF
$22.5B
$224K 0.05%
2,600
-5,100
-66% -$410K
MNSO icon
495
MINISO
MNSO
$3.67B
$223K 0.05%
+10,900
New +$209K
ENOV icon
496
Enovis
ENOV
$1.74B
$223K 0.05%
3,563
-8,510
-70% -$509K
RY icon
497
Royal Bank of Canada
RY
$294B
$222K 0.05%
2,200
-20,806
-90% -$2.05M
NVCR icon
498
NovoCure
NVCR
$1.87B
$220K 0.05%
+14,103
New +$207K
TEVA icon
499
Teva Pharmaceuticals
TEVA
$40.5B
$220K 0.05%
15,600
+300
+2% +$3.78K
IPAR icon
500
Interparfums
IPAR
$3.95B
$220K 0.05%
+1,563
New +$221K

Similar funds

AXQ Capital's Q1 2024 Portfolio in Review

As of Q1 2024, AXQ Capital held 929 positions worth $417M, up 11% from $375M the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

AXQ Capital deployed $20.4M of net new capital in Q1 2024, opening 309 new positions and adding to 146 existing holdings. Its largest new stake was S&P Global: 8,000 shares worth $3.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Aon, an estimated $2.38M trimmed.

  • AXQ Capital's largest Q1 2024 buy was S&P Global: 8,000 shares worth $3.4M.
  • AXQ Capital added most to Globe Life in Q1 2024, an estimated $2.13M increase.
  • AXQ Capital's biggest Q1 2024 reduction was Aon, cutting an estimated $2.38M.
  • AXQ Capital fully exited Cigna in Q1 2024, selling an estimated $2.28M.
  • AXQ Capital's ten largest holdings make up 6.4% of its $417M portfolio in Q1 2024.
  • AXQ Capital opened 309 new positions and closed 333 in Q1 2024.
  • AXQ Capital's portfolio value rose 11% quarter-over-quarter to $417M.

Based on AXQ Capital's 13F filing for Q1 2024, filed 14 May 2024.